387 related articles for article (PubMed ID: 33581505)
1. Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
Parag-Sharma K; Tasoulas J; Musicant AM; do Nascimento-Filho CHV; Zhu Z; Twomey C; Liu P; Castilho RM; Amelio AL
Oral Oncol; 2021 Apr; 115():105166. PubMed ID: 33581505
[TBL] [Abstract][Full Text] [Related]
2. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
3. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
[TBL] [Abstract][Full Text] [Related]
4. Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
Ahn MY; Ahn JW; Kim HS; Lee J; Yoon JH
Oncol Rep; 2015 Apr; 33(4):1899-907. PubMed ID: 25647264
[TBL] [Abstract][Full Text] [Related]
5. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
6. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
8. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
[TBL] [Abstract][Full Text] [Related]
9. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.
Lujan B; Hakim S; Moyano S; Nadal A; Caballero M; Diaz A; Valera A; Carrera M; Cardesa A; Alos L
Br J Cancer; 2010 Aug; 103(4):510-6. PubMed ID: 20664595
[TBL] [Abstract][Full Text] [Related]
10. Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.
Wagner VP; Martins MD; Martins MAT; Almeida LO; Warner KA; Nör JE; Squarize CH; Castilho RM
Sci Rep; 2018 Feb; 8(1):2065. PubMed ID: 29391537
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
Zhang L; Zhang Y; Mehta A; Boufraqech M; Davis S; Wang J; Tian Z; Yu Z; Boxer MB; Kiefer JA; Copland JA; Smallridge RC; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Apr; 6(11):9073-85. PubMed ID: 25940539
[TBL] [Abstract][Full Text] [Related]
12. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
[TBL] [Abstract][Full Text] [Related]
13. High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.
Lee H; Roh JL; Choi YJ; Choi J; Cho KJ
Head Neck Pathol; 2020 Sep; 14(3):822-827. PubMed ID: 31535311
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
[TBL] [Abstract][Full Text] [Related]
15. CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.
Cao W; Yao S; Li A; Chen H; Zhang E; Cao L; Zhang J; Hou Y; Dai Z; Chen J; Huang X; Yang L; Cai Z
J Zhejiang Univ Sci B; 2023 May; 24(5):442-454. PubMed ID: 37190893
[TBL] [Abstract][Full Text] [Related]
16. The molecular landscape of breast mucoepidermoid carcinoma.
Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
[TBL] [Abstract][Full Text] [Related]
17. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Ma L; Bian X; Lin W
J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.
Cai X; Zhai HX; Wang J; Forrester J; Qu H; Yin L; Lai CJ; Bao R; Qian C
J Med Chem; 2010 Mar; 53(5):2000-9. PubMed ID: 20143778
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of epithelial cell adhesion molecule (EpCAM) in mucoepidermoid carcinoma compared to normal salivary gland tissues.
Kamal NM; Salem HM; Dahmoush HM
Arch Oral Biol; 2017 Jul; 79():87-94. PubMed ID: 28347886
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications.
Bell D; El-Naggar AK
Head Neck Pathol; 2013 Mar; 7(1):23-7. PubMed ID: 23459841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
